The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 dose-escalation and expansion study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, given as monotherapy and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer.
 
Christine H. Chung
Consulting or Advisory Role - Brooklyn ImmunoTherapeutics; Exelixis; Fulgent Pharma; Genmab; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Regeneron (Inst)
 
A. Dimitrios Dimitrios Colevas
Consulting or Advisory Role - Alpha BioCom; Beigene; ClearView Healthcare Partners; Deallus; Gilead Sciences; leidos biomedical research
Research Funding - Abbvie; AstraZeneca; Atara Biotherapeutics; BioNtech; BMS; CUE Biopharma; Cullinan Oncology; Exelixis; Experimental Therapeutics Clinical Trials Network (ETCTN); Forty Seven; Innate Pharma; Merck; NIH/NCI; NRG Oncology; Tessa Therapeutics
 
Douglas Adkins
Consulting or Advisory Role - Boehringer Ingelheim; Calliditas Therapeutics; CUE Biopharma; Eisai Europe; Exelixis; Genmab/Seattle Genetics; Gilead Sciences; Immunitas; Jazz Pharmaceuticals; Kura Oncology; Merck; Seagen; TargImmune Therapeutics; Vaccinex
Research Funding - Adlai Nortye (Inst); AstraZeneca (Inst); BeiGene (Inst); BioAtla (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calliditas Therapeutics (Inst); Celgene (Inst); Cofactor Genomics (Inst); CUE Biopharma (Inst); Debiopharm Group (Inst); Epizyme (Inst); Genmab (Inst); Gilead Sciences (Inst); Hookipa Biotech (Inst); Immutep (Inst); ISA Pharmaceuticals (Inst); Kura Oncology (Inst); Lilly (Inst); Merck (Inst); NATCO Pharma (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Tizona Therapeutics, Inc. (Inst); Vaccinex (Inst)
 
Cristina P. Rodriguez
Consulting or Advisory Role - Abbvie (I); ADC Therapeutics (I); AstraZeneca (I); beigene (I); Coherus Biosciences; Incyte (I); Karyopharm Therapeutics (I); Kite, a Gilead company (I); Millenium Pharamceuticals (I); Millenium Pharamceuticals (I)
Research Funding - AstraZeneca/MedImmune (Inst); Ayala Pharmaceuticals (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CUE Biopharma (Inst); Denovo Biopharma (Inst); Genentech (Inst); Ignyta (Inst); Incyte (Inst); Kura Oncology (Inst); Merck (Inst)
 
Jong Chul Park
Consulting or Advisory Role - GC Cell; Gene Medicine; MitoImmune; Selecxine
 
Michael K. Gibson
No Relationships to Disclose
 
Barbara Burtness
Consulting or Advisory Role - Abbvie; ALX Oncology; Arvinas; Coherus Biosciences; CUE Biopharma; Genentech/Roche; IO Biotech; Kura Oncology; Macrogenics; Merck; Merck KGaA; Vaccinex
Speakers' Bureau - Clinical Education Alliance; Oncology Education
Research Funding - CUE Biopharma (Inst); Exelixis (Inst); Merck; Merck (Inst)
 
Faye M. Johnson
Honoraria - Emory University; Methodist Hospital
Research Funding - CUE Biopharma (Inst); PIQUR; Puma Biotechnology (Inst); Takeda; Takeda (Inst); Trovagene; Viracta Therapeutics (Inst)
 
Ricklie Ann Julian
Consulting or Advisory Role - Jazz Pharmaceuticals
 
Nabil F. Saba
Honoraria - American Journal OF Managed Care; AstraZeneca; Eisai; EMD Serono; Exelixis; GlaxoSmithKline; Inovio Pharmaceuticals; Merck; Novartis; vaccinex
Research Funding - Bristol-Myers Squibb; Exelixis
Patents, Royalties, Other Intellectual Property - Springer textbook Royalty; Uptodate chapter writing and editing
Travel, Accommodations, Expenses - Merck
 
Francis P. Worden
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Merck Sharp & Dohme; Regeneron
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; eisai; Exelixis; Loxo; Merck; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); CUE Biopharma (Inst); Eisai (Inst); Lilly (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Sharp & Dohme
 
Lara Dunn
Consulting or Advisory Role - Merck
Research Funding - CUE Biopharma; Nektar; Regeneron; Replimune; Seagan; Seagan
 
Tanguy Y. Seiwert
Honoraria - Coherus Biosciences; Merck; Nanobiotix
Consulting or Advisory Role - Bayer; BioNTech SE; BostonGene; CUE Biopharma; Innate Pharma; IO Biotech; Merck; Nanobiotix; Nektar; Sanofi; VIR Biotechnology
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cue Biopharma (Inst); Dracen (Inst); Genentech/Roche (Inst); Merck (Inst); Nanobiotix (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - BostonGene; Coherus Biosciences; Nanobiotix
 
Robert M. Jotte
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Roche; Mirati Therapeutics
 
Julie E. Bauman
Consulting or Advisory Role - BlueDot; Exelixis
Research Funding - AstraZeneca (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); CUE Biopharma (Inst); Lilly (Inst); Moderna Therapeutics (Inst); Novartis (Inst)
 
Marya F. Chaney
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Steven Margossian
Employment - Cue Biopharma
Stock and Other Ownership Interests - Cue Biopharma
Patents, Royalties, Other Intellectual Property - Cue Biopharma
 
Matteo Levisetti
Employment - Cue Biopharma
Leadership - Cue Biopharma
Stock and Other Ownership Interests - Cue Biopharma
Patents, Royalties, Other Intellectual Property - Cue Biopharma
 
Sara I. Pai
Consulting or Advisory Role - Cue Biopharma; Merck; Parthenon Therapeutics; Replimune; Scopus BioPharma; Sensei Biotherapeutics
Research Funding - Abbvie; AstraZeneca (Inst); Cue Biopharma; Merck (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca/MedImmune; Merck